Invo Fertility earnings were -$9.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IVF earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.9M, up 137.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IVF reported annual earnings of -$9.3M, with 16.3% growth.
Invo Fertility (NASDAQ: IVF) reported Q4 2024 earnings per share (EPS) of -$10.51, up 700.57% year over year. Total IVF earnings for the quarter were -$3.87 million. In the same quarter last year, Invo Fertility's earnings per share (EPS) was $1.75.
As of the last Invo Fertility earnings report, Invo Fertility is currently losing money. Invo Fertility's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$9.10 million, a 13.21% increase year over year.
What was IVF's earnings growth in the past year?
As of Invo Fertility's earnings date in Q2 2025, Invo Fertility's earnings has grown year over year. IVF earnings in the past year totalled -$9.35 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.